Group 1 - The U.S. stock market has rebounded from recent lows, but traders are significantly increasing their allocation to defensive assets [1] - Despite President Trump's announcement to pause tariffs on most goods for 90 days, investors focusing on safe sectors have achieved better returns than those in riskier areas [1][2] - Barclays data shows that defensive stock portfolios generally outperform cyclical stocks during market upswings, and continue to lead when market sentiment worsens [1][3] Group 2 - Financially weaker companies have seen a 3.3% decline in stock prices after the tariff pause announcement, underperforming healthier companies [1] - Keith Lerner from Truist Advisory Services indicates a shift towards traditional defensive strategies, suggesting that investors are waiting for clearer market signals [1][2] - Defensive sectors like utilities, consumer staples, and healthcare tend to be more resilient during economic downturns, providing stable earnings and relatively smooth returns [2] Group 3 - The shift towards defensive companies reflects changes in market behavior and risk-return dynamics, particularly evident in the AI sector, which has recently faced significant declines [3] - High-growth companies are struggling due to factors beyond their control, prompting investors to pivot towards defensive sectors in preparation for further market volatility [3]

Market Overview - The A-share market exhibited significant structural differentiation from April 14 to April 18, with major indices showing mixed performance. The Shanghai Composite Index rose by 1.19%, while the Shenzhen Index and the ChiNext Index fell by 0.54% and 0.64%, respectively [1] - The market sentiment was influenced by a shift in investment style, with funds moving from high-volatility technology sectors to traditional industries with stable cash flows. Blue-chip and high-dividend strategies performed well, while growth sectors continued to decline [1] Industry Performance - Concerns over supply chain disruptions led to a slowdown in economic recovery, affecting sectors such as industrials, consumer discretionary, healthcare, and information technology, with the latter experiencing the largest decline, though not exceeding 0.8% [1] - Real estate, telecommunications services, and utilities showed relatively strong performance, with real estate rising by 3.47% [1] Fund Issuance and Performance - A total of 25 funds were issued last week, including 17 equity funds, 7 bond funds, and 1 fund of funds (FOF), with a total issuance of 20.476 billion units [2][18] - The total index for Chinese funds increased by 0.02%, while the ordinary equity fund index decreased by 0.08%, and the mixed equity fund index fell by 0.04% [2] Global Asset Review - Global asset prices showed mixed performance, with U.S. indices under pressure, while European markets strengthened. The Dow Jones and Nasdaq indices fell by over 2%, while major Asian indices rose by over 2% [4] - In commodities, the energy sector led gains, while industrial metals showed mixed results. Gold prices rose nearly 3% due to increased risk aversion, reaching over $3,300 per ounce [4] Domestic Bond Market - The bond market remained stable, with the 10-year government bond futures rising by 0.04% and the 30-year futures increasing by 0.03%. Domestic long-term interest rates remained at historical lows [16]

Group 1 - The Hang Seng Healthcare Index (HSHCI) has seen a strong increase of 2.95%, with notable gains from companies such as Zai Lab (09688) up 12.39% and Dongyangguang Changjiang Pharmaceutical (01558) up 9.04% [3] - The Hang Seng Healthcare ETF (513060) has risen by 3.15%, marking its fourth consecutive increase, with a recent price of 0.46 yuan [3] - Over the past three months, the Hang Seng Healthcare ETF has accumulated a total increase of 21.98% [3] Group 2 - The Hang Seng Healthcare ETF has experienced a net value increase of 26.66% over the past year, with the highest single-month return reaching 28.34% since its inception [4] - The ETF's Sharpe ratio stands at 1.27, indicating strong risk-adjusted returns [4] - The ETF's management fee is 0.50%, and the custody fee is 0.15% [4] Group 3 - The top ten weighted stocks in the Hang Seng Healthcare Index account for 56.37% of the index, with companies like BeiGene (06160) and WuXi Biologics (02269) leading the list [5] - The performance of these stocks varies, with BeiGene showing a gain of 5.34% and WuXi Biologics up by 2.81% [7] Group 4 - The current market environment emphasizes the importance of domestic consumption growth due to pressures from U.S.-China tariffs, highlighting healthcare consumption as a key investment area [8] - The market sentiment is recovering, with a focus on undervalued blue-chip stocks and companies with solid fundamentals, particularly in the healthcare sector [8]

2025 年 4 月 11 日 招银国际环球市场 | 市场策略 | 招财日报 每日投资策略 宏观及公司点评 全球市场观察 招银国际研究部 邮件：research@cmbi.com.hk | 环球主要股市上日表现 | | | | | --- | --- | --- | --- | | | 收市价 | | 升跌（%） | | | | 单日 | 年内 | | 恒生指数 | 20,682 | 2.06 | 21.32 | | 恒生国企 | 7,668 | 1.76 | 32.94 | | 恒生科技 | 4,814 | 2.66 | 27.88 | | 上证综指 | 3,224 | 1.16 | 8.36 | | 深证综指 | 1,868 | 2.46 | 1.66 | | 深圳创业板 | 1,901 | 2.27 | 0.48 | | 美国道琼斯 | 39,594 | -2.50 | 5.05 | | 美国标普 500 | 5,268 | -3.46 | 10.45 | | 美国纳斯达克 | 16,387 | -4.31 | 9.17 | | 德国 DAX | 20,563 | 4.53 | 22.75 | | 法国 ...

Core Viewpoint - The article discusses the implications of Trump's recent "reciprocal tariff" executive order, which imposes a 10% minimum tariff on global trade partners and a 34% tariff specifically on China, highlighting the potential economic risks and market reactions associated with this policy [1][2][3]. Group 1: Objectives of the Tariff Policy - The primary goal of the tariff policy is to alleviate the U.S. debt burden by increasing revenue through higher tariffs [5]. - Another objective is to stimulate the return of manufacturing jobs to the U.S. by making domestic production more financially attractive [6]. - The policy aims to reshape the geopolitical landscape and re-establish U.S. dominance in international trade [7]. Group 2: Market Reactions - Following the announcement, U.S. stock markets experienced significant declines, with the Dow Jones dropping 2.72%, S&P 500 down 3.16%, and Nasdaq falling 4.24% within two days [12]. - Global markets also reacted negatively, with Japan's Nikkei 225 index down 2.6% and Vietnam's stock market plummeting 7% [13]. - The volatility in the markets reflects concerns over the uncertainty of the tariff policy and its long-term implications [14]. Group 3: Investment Strategies - In the U.S. market, a cautious approach is recommended, avoiding high-valuation tech stocks and focusing on defensive sectors such as utilities and healthcare [24]. - For Hong Kong stocks, it is advised to reduce exposure to export-oriented companies and increase holdings in domestic consumption and financial sectors [34]. - In the A-share market, investors are encouraged to consider undervalued blue-chip stocks and sectors benefiting from domestic demand and technological advancements [34]. Group 4: China's Response and Market Risks - China is likely to implement reciprocal tariffs on U.S. goods, particularly in agriculture and energy, while also diversifying its export markets [37]. - Long-term strategies may include tax reductions and infrastructure investments to boost domestic demand, alongside enhancing regional trade cooperation [38]. - Potential risks include increased import costs leading to domestic inflation and the impact of reduced U.S. demand on export-oriented companies [38].

Core Insights - The Edge AI Foundation has rebranded from the TinyML Foundation and released the "2025 Edge AI Technology Report," highlighting the maturity and real-world applications of TinyML [1][3]. Group 1: Edge AI Technology Drivers - The report discusses advancements in hardware and software that support Edge AI deployment, focusing on innovations in dedicated processors and ultra-low power devices [3]. - Edge AI is transforming operational models across various industries by enabling real-time analysis and decision-making capabilities [3]. Group 2: Industry Applications of Edge AI - In the automotive sector, Edge AI enhances safety and response times, with examples like Waymo and NIO utilizing real-time data processing for improved performance [7][8]. - Manufacturing benefits from Edge AI through predictive maintenance, quality control, and process optimization, with reported reductions in maintenance costs by 30% and downtime by 45% [9][12]. - In healthcare, localized AI accelerates diagnostics and improves patient outcomes by analyzing medical data directly on devices [14]. - Retail operations are optimized through real-time behavior analysis and AI-driven systems, reducing checkout times by 30% [16]. - Logistics is enhanced by integrating Edge AI with IoT sensors, allowing for immediate analysis of data and optimization of supply chain operations [18]. - Smart agriculture utilizes Edge AI for precision farming, reducing water usage by 25% and pesticide use by 30% [21]. Group 3: Edge AI Ecosystem and Collaboration - The Edge AI ecosystem relies on collaboration among hardware vendors, software developers, cloud providers, and industry stakeholders to avoid fragmentation [24]. - A three-layer architecture is recognized for Edge AI, distributing workloads across edge devices, edge servers, and cloud platforms [24][25]. - Cross-industry partnerships are increasing, with companies like Intel and Qualcomm collaborating to enhance Edge AI deployment [26][27]. Group 4: Emerging Trends in Edge AI - Five emerging trends are reshaping Edge AI, including federated learning, quantum neural networks, and neuromorphic computing [30]. - Federated learning is expected to enhance model adaptability and collaboration across industries, with a projected market value of nearly $300 million by 2030 [31]. - Quantum computing is set to redefine Edge AI capabilities, enabling faster decision-making and real-time processing [34][36]. - AI-driven AR/VR applications are evolving with Edge AI, allowing for real-time responses and improved energy efficiency [39]. - Neuromorphic computing is gaining traction for its energy efficiency and ability to handle complex tasks without cloud connectivity [41].

Group 1 - The Hang Seng Healthcare Index (HSHCI) has seen a strong increase of 1.80%, with notable gains from companies such as Lepu Biopharma-B (up 16.56%) and Zai Lab (up 10.27%) [1] - The Hang Seng Medical ETF (513060) has risen by 2.11%, marking its third consecutive increase, with a trading volume of 4.69 billion yuan [1][2] - The second Boao Lecheng Stem Cell Conference has opened, marking a new phase of standardized and high-quality development in China's stem cell industry [2] Group 2 - Financial analysts predict that the approval and implementation of more projects in the stem cell sector will lead to advanced treatment methods benefiting the public [2] - The domestic medical innovation industry is expected to experience multiple growth opportunities, particularly for companies with true innovation capabilities in new drug development [2] - The Hang Seng Medical ETF has seen a significant growth in scale, increasing by 34.09 billion yuan over the past year, ranking in the top third among comparable funds [2] Group 3 - Since its inception, the Hang Seng Medical ETF has achieved a maximum monthly return of 28.34% and an average monthly return of 7.00% [3] - The ETF has outperformed its benchmark with an annualized excess return of 2.02% over the past year [3] - The ETF's management fee is 0.50%, and the custody fee is 0.15% [3] Group 4 - The tracking error of the Hang Seng Medical ETF is 0.033%, the highest tracking precision among comparable funds [4] - The latest price-to-earnings ratio (PE-TTM) of the Hang Seng Medical Healthcare Index is 24.97, indicating it is at a historical low compared to the past year [4] - The top ten weighted stocks in the Hang Seng Medical Healthcare Index account for 55.64% of the index, with companies like WuXi Biologics and BeiGene among the leaders [4][6]

Investment Rating - The report does not explicitly provide an investment rating for the industry or specific companies [1]. Core Insights - The report highlights a general cooling of inflation in the U.S., with February CPI rising 2.8%, lower than the expected 2.9% and previous 3% [6][20]. - The report indicates that the Chinese government has launched a "Consumption Promotion Special Action Plan" to boost domestic demand, reflecting a consensus among decision-makers to enhance consumption [26][23]. - The report notes that the A-share market has shown strong performance, leading among global indices, with policies aimed at stimulating domestic consumption expected to benefit the consumer sector [21][23]. Summary by Sections U.S. Economic Data - February CPI data shows a year-on-year increase of 2.8%, with core CPI rising 3.1%, both lower than expectations [6][20]. - February PPI data indicates a year-on-year increase of 3.2%, also below expectations, suggesting a short-term easing of inflation [5][6]. Japanese Economic Data - Japan's Q4 GDP was revised down to a seasonally adjusted annualized growth of 2.2%, lower than the expected 2.8%, with personal consumption remaining flat [10]. Chinese Financial Data - As of the end of February, M2 money supply was 320.52 trillion yuan, growing 7% year-on-year, while social financing stock was 417.29 trillion yuan, up 8.2% year-on-year [15][16]. - The report indicates a significant increase in government bond issuance to address local debt, with nearly 800 billion yuan in replacement bonds issued [15]. Stock Market Insights - The report notes that the Indian market is underperforming compared to global indices, with a projected GDP growth of only 6.5% for 2025 [21]. - The consumer sector in China is expected to benefit from policy support aimed at boosting domestic consumption, with notable gains in the beauty and food & beverage sectors [21][26]. Bond Market Overview - The U.S. bond market experienced fluctuations due to concerns over tariffs and inflation data, with the 10-year Treasury yield rising to 4.32% [33][36]. - The Chinese bond market remains cautious, with the 10-year government bond yield increasing to 1.89% amid a stable funding environment [34][36].

Group 1: Asset Structure - The asset structure of Chinese technology assets shows that A-shares are more focused on manufacturing, while Hong Kong and US stocks lean towards internet software services and new energy vehicle sectors [9][10][11] - In A-shares, technology assets account for nearly 50% of the market, with hardware and electrical equipment dominating [9] - In Hong Kong, technology assets represent 61% of the market, with a balanced distribution between technology services and manufacturing [10] - In the US, technology assets account for approximately 92% of the market, predominantly in software services and internet companies [11] Group 2: Performance Comparison - Since 2024, the revenue and profit growth rates of technology assets in Hong Kong and the US have surpassed those in A-shares, with ROE_TTM also beginning to exceed A-shares [21][22] - As of Q3 2024, the revenue growth rates for A-shares, Hong Kong, and US-listed Chinese technology assets were 3.5%, 7.5%, and 14.1% respectively, while net profit growth rates were -11.3%, 31.2%, and 76.1% [23] - The profitability of technology assets in Hong Kong and the US is significantly higher, particularly in the software services and media sectors, compared to A-shares [32][33] Group 3: Valuation Comparison - The valuation of A-shares is generally lower than that of Hong Kong and US stocks, with A-share technology indices trading at historical averages [6][21] - As of March 11, 2025, the PE ratios for A-shares' ChiNext 50 and Sci-Tech Innovation 50 indices were 32x and 41x, while Hong Kong's Hang Seng Tech index was at 25x [21] - The PS ratios for A-shares' Sci-Tech 50 and Sci-Tech 100 indices were 5x and 6.8x, indicating a potential for upward valuation adjustments [21] Group 4: Investment Outlook - The report suggests that the revaluation of Chinese technology assets is expected to continue, with each market having its unique advantages [5][21] - The ongoing support for technological innovation from government policies, particularly in AI and robotics, is anticipated to drive further interest in these assets [5][21]

证 券 研 究 报 告 恒生科技涨幅靠前，但资金仍未系统性增配 www.swsresearch.com 证券研究报告 2 ◼ 2025年2月，伴随着DeepSeek影响的持续发酵，内外资对于中国科技资产情绪转乐观。1）权益层面，阿里巴巴公布Q4业绩超预期， 同时宣布的大规模AI投资进一步推升投资者预期。本月恒生科技美元计价上涨11%，远远强于其他指数。2）利率层面，美联储月初保持 现有利率水平，符合市场预期，但是会议纪要显示各委员态度偏鹰，但美国经济中PMI数据下滑，10Y美债收益率本月下降30BPs。3） 商品层面，俄乌战争局势影响美欧天然气价格，本月美气上涨明显，美国债务问题愈发突出，贵金属涨幅明显，Comex黄金上涨6%。 ◼ 全球资金流向来看，近一个月以来（截止2025年3月5日），全球货币市场资金和发达市场股市获得资金流入，新兴市场股市资金流出。 国别和地区上，美国的权益和固收基金资金流入超过其他市场，发达市场资金流入超过新兴市场。 ◼ 全球资金配置中国市场方面，截止2025年2月27日，2月全球权益基金资金流出中国市场的规模为174.1亿美元，1月为流入34.4亿美元， 由流入转为流出。1）从流入 ...